News
"The collaborative nature of different institutions in his work within southern Louisiana inspired me," said Dr. Adithya Hari ...
MP0726, a Radio-DARPin candidate targeting mesothelin (MSLN) and intended for the treatment of ovarian cancer, is nominated for development under strategic partnership with Orano MedPromising tumor ...
Ratio Therapeutics and Ionetix have inked separate deals to boost production of the much-needed radioisotope actinium-225, ...
4d
The Daily Galaxy on MSNNASA’s Curiosity Just Parked on Mars—And Made an Unprecedented DiscoveryOn Sols 4575 and 4576 of its mission, NASA’s Curiosity rover reached what its team is calling one of the most stable and ...
Archeus Technologies, a company developing radiopharmaceutical therapies for the treatment of patients with cancer, today announced that the U.S. Food and Drug Administration (FDA) has cleared its ...
A study published in Frontiers of Agricultural Science and Engineering (DOI: 10.15302/J-FASE-2024598) by Vipul Kumar from ...
The company raised $425 million in January 2025, around the same time that it turned on Polaris, a prototype reactor. Helion ...
In a prostate cancer mouse model (22Rv1 xenografts), the combination of 225 Ac-YS5 (0.12 µCi) + YS5-MMAE (1.8 mg/kg) was associated with the most significant reduction in tumor volume (green curves in ...
Medical machines like MRI, CT, and PET imaging systems are produced with parts that have high accuracy, are harmless to the ...
The firm hopes to overcome common dose-limiting toxicities with its PSMA-targeted radiotherapy while boosting potency versus competitors.
The Alpha Magnetic Spectrometer (AMS-02), a particle physics detector installed on the International Space Station (ISS), is ...
2don MSN
Acquiring high-value status is not viewed merely as key for success in life, but also for attracting “high-value” women as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results